{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:02:50Z","timestamp":1784797370095,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106325","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T12:02:06Z","timestamp":1655899326000},"page":"106325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study"],"prefix":"10.1016","volume":"182","author":[{"given":"Abdulla","family":"Watad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saar","family":"Anis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Carmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishai M.","family":"Tsur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Ben-Shabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Luigi Bragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106325_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3899\/jrheum.130959","article-title":"Classification and diagnosis of axial spondyloarthritis - What is the clinically relevant difference?","volume":"Vol. 42","author":"Braun","year":"2015","journal-title":"J. Rheumatol. J. Rheumatol."},{"issue":"18","key":"10.1016\/j.phrs.2022.106325_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor \u03b1","volume":"346","author":"Gorman","year":"2002","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.phrs.2022.106325_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"7","key":"10.1016\/j.phrs.2022.106325_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+ CD4- CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med"},{"issue":"8","key":"10.1016\/j.phrs.2022.106325_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/annrheumdis-2020-217309","article-title":"Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression","volume":"79","author":"Watad","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2022.106325_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11926-014-0434-7","article-title":"Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice","volume":"16","author":"Mercieca","year":"2014","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.phrs.2022.106325_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-319-59963-2_5","article-title":"Ankylosing spondylitis","author":"Kiltz","year":"2017","journal-title":"Comorbidity Rheum. Dis."},{"key":"10.1016\/j.phrs.2022.106325_bib8","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"Vol. 2015","author":"Maxwell","year":"2015"},{"issue":"11","key":"10.1016\/j.phrs.2022.106325_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for rheumatoid arthritis and risk of alzheimer\u2019s disease: a nested case-control analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2022.106325_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"Vol. 11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106325_bib11","article-title":"Mortality in ankylosing spondylitis according to treatment: a nationwide retrospective cohort study of 5900 patients from Israel","author":"Ben-Shabat","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.phrs.2022.106325_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.rdc.2012.08.010","article-title":"Comorbidities in patients with spondyloarthritis","volume":"38","author":"van der Horst-Bruinsma","year":"2012","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"10","key":"10.1016\/j.phrs.2022.106325_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/kel115","article-title":"Disease and psychological status in ankylosing spondylitis","volume":"45","author":"Martindale","year":"2006","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.phrs.2022.106325_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcl005","article-title":"Neurological involvement in patients with rheumatic disease","volume":"99","author":"Sofat","year":"2006","journal-title":"QJM - Mon. J. Assoc. Physicians"},{"issue":"11","key":"10.1016\/j.phrs.2022.106325_bib15","first-page":"2120","article-title":"Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis","volume":"22","author":"Ramos-Remus","year":"1995","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2022.106325_bib16","unstructured":"Oh DH, Jun JB, Kim HT, Lee SW, Jung SS, Lee IH, et al. Transverse myelitis in a patient with long-standing ankylosing spondylitis. Clin Exp Rheumatol. 19(2):195\u2013196."},{"issue":"5899","key":"10.1016\/j.phrs.2022.106325_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.1.5899.148","article-title":"Nervous system involvement in ankylosing spondylitis","volume":"1","author":"Thomas","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.phrs.2022.106325_bib18","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"IMAJ"},{"key":"10.1016\/j.phrs.2022.106325_bib19","first-page":"2020","article-title":"Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study","volume":"4","author":"Ben-Shabat","year":"2019","journal-title":"J. Rheuma"},{"issue":"5","key":"10.1016\/j.phrs.2022.106325_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"1","key":"10.1016\/j.phrs.2022.106325_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(01)00604-9","article-title":"Reversible parkinsonism in systemic lupus erythematosus","volume":"193","author":"Tan","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"18","key":"10.1016\/j.phrs.2022.106325_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: a population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106325_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210335","article-title":"Relationship between dementia and ankylosing spondylitis: a nationwide, population-based, retrospective longitudinal cohort study","volume":"14","author":"Jang","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2022.106325_bib24","doi-asserted-by":"crossref","DOI":"10.1017\/cjn.2020.14","article-title":"Cognitive impairment in patients with ankylosing spondylitis","volume":"47","author":"Vitturi","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2022.106325_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer\u2019s disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2022.106325_bib26","first-page":"149","article-title":"Long-term inflammation increases risk of common mental disorder: A cohort study","volume":"Vol. 19","author":"Kivim\u00e4ki","year":"2014"},{"key":"10.1016\/j.phrs.2022.106325_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3349\/ymj.2007.48.2.218","article-title":"Serum amyloid A as a useful indicator of disease activity in patients with ankylosing spondylitis","volume":"Vol. 48","author":"Jung","year":"2007","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106325_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960050114","article-title":"Serum amyloid A - an indicator of inflammation in ankylosing spondylitis","volume":"19","author":"Lange","year":"2000","journal-title":"Rheuma Int"},{"key":"10.1016\/j.phrs.2022.106325_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517709278","article-title":"Tumor necrosis factor \u03b1 Inhibition for Alzheimer\u2019s Disease","volume":"9","author":"Chang","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2022.106325_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02629-w","article-title":"Positive association of Parkinson\u2019s disease with ankylosing spondylitis: a nationwide population-based study","volume":"18","author":"Yeh","year":"2020","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2022.106325_bib31","series-title":"Parkinsonism and Related Disorders","first-page":"S3","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","author":"McGeer","year":"2004"},{"key":"10.1016\/j.phrs.2022.106325_bib32","first-page":"1005","article-title":"Parkinson\u2019s disease: Autoimmunity and neuroinflammation","volume":"Vol. 15","author":"De Virgilio","year":"2016"},{"issue":"22","key":"10.1016\/j.phrs.2022.106325_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"Pt B","key":"10.1016\/j.phrs.2022.106325_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2022.106325_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106325_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.imbio.2017.10.036","article-title":"Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: Is TNF alpha the link?","volume":"223","author":"Drori","year":"2018","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.phrs.2022.106325_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"Ong","year":"2014","journal-title":"JAMA Neurol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:44:02Z","timestamp":1760913842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"alternative-id":["S1043661822002705"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106325","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106325"}}